human ca ix quantikine elisa kit Search Results


ca9  (R&D Systems)
94
R&D Systems ca9
A <t>CA9</t> levels in healthy patients, patients with cirrhosis only and patients with hepatocellular carcinoma. B CA9 levels in different stages of Child Pugh in HCC patients. C CA9 levels in different stages of HCC according to BCLC. D CA9 levels in different stages of HCC according to ALBI score. (*, P<0.01). Vertical lines indicate the range, the horizontal boundaries of the boxes represent the first and third quartile.
Ca9, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ca9/product/R&D Systems
Average 94 stars, based on 1 article reviews
ca9 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
human ca125/muc16 quantikine elisa kit  (Bio-Techne corporation)
94
Bio-Techne corporation human ca125/muc16 quantikine elisa kit
A <t>CA9</t> levels in healthy patients, patients with cirrhosis only and patients with hepatocellular carcinoma. B CA9 levels in different stages of Child Pugh in HCC patients. C CA9 levels in different stages of HCC according to BCLC. D CA9 levels in different stages of HCC according to ALBI score. (*, P<0.01). Vertical lines indicate the range, the horizontal boundaries of the boxes represent the first and third quartile.
Human Ca125/Muc16 Quantikine Elisa Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ca125/muc16 quantikine elisa kit/product/Bio-Techne corporation
Average 94 stars, based on 1 article reviews
human ca125/muc16 quantikine elisa kit - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
quantikinevr elisa human caix immunoassay dca900  (R&D Systems)
93
R&D Systems quantikinevr elisa human caix immunoassay dca900
A <t>CA9</t> levels in healthy patients, patients with cirrhosis only and patients with hepatocellular carcinoma. B CA9 levels in different stages of Child Pugh in HCC patients. C CA9 levels in different stages of HCC according to BCLC. D CA9 levels in different stages of HCC according to ALBI score. (*, P<0.01). Vertical lines indicate the range, the horizontal boundaries of the boxes represent the first and third quartile.
Quantikinevr Elisa Human Caix Immunoassay Dca900, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quantikinevr elisa human caix immunoassay dca900/product/R&D Systems
Average 93 stars, based on 1 article reviews
quantikinevr elisa human caix immunoassay dca900 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

Image Search Results


A CA9 levels in healthy patients, patients with cirrhosis only and patients with hepatocellular carcinoma. B CA9 levels in different stages of Child Pugh in HCC patients. C CA9 levels in different stages of HCC according to BCLC. D CA9 levels in different stages of HCC according to ALBI score. (*, P<0.01). Vertical lines indicate the range, the horizontal boundaries of the boxes represent the first and third quartile.

Journal: PLoS ONE

Article Title: Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis

doi: 10.1371/journal.pone.0200855

Figure Lengend Snippet: A CA9 levels in healthy patients, patients with cirrhosis only and patients with hepatocellular carcinoma. B CA9 levels in different stages of Child Pugh in HCC patients. C CA9 levels in different stages of HCC according to BCLC. D CA9 levels in different stages of HCC according to ALBI score. (*, P<0.01). Vertical lines indicate the range, the horizontal boundaries of the boxes represent the first and third quartile.

Article Snippet: CA9 was measured using a commercially available sandwich ELISA (Quantikine Elisa, Human Carbonic Anhydrase IX Immunoassay, DCA900, RND Systems) according to the recommendation of the manufacturer.

Techniques:

A Median CA9 levels according to etiology of liver disease in patients with HCC compared to patients with cirrhosis only. (*, P<0.01). A CA9 levels in different stages of Child Pugh in cirrhotic patients. Vertical lines indicate the range, the horizontal boundaries of the boxes represent the first and third quartile.

Journal: PLoS ONE

Article Title: Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis

doi: 10.1371/journal.pone.0200855

Figure Lengend Snippet: A Median CA9 levels according to etiology of liver disease in patients with HCC compared to patients with cirrhosis only. (*, P<0.01). A CA9 levels in different stages of Child Pugh in cirrhotic patients. Vertical lines indicate the range, the horizontal boundaries of the boxes represent the first and third quartile.

Article Snippet: CA9 was measured using a commercially available sandwich ELISA (Quantikine Elisa, Human Carbonic Anhydrase IX Immunoassay, DCA900, RND Systems) according to the recommendation of the manufacturer.

Techniques:

A Mortality according to CA9 levels in patients with HCC. Patients with high serum CA9 concentrations had an increased mortality risk (hazard ratio (HR) 1.690, 95% confidence interval (CI) 1.017–2.809, p = 0.043). B Mortality according to CA9 levels in patients with cirrhosis. Patients with high serum CA9 concentrations had an increased mortality risk in this cohort (hazard ratio (HR) 2.458, 95% confidence interval (CI) 1.010–6.114, p = 0.048).

Journal: PLoS ONE

Article Title: Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis

doi: 10.1371/journal.pone.0200855

Figure Lengend Snippet: A Mortality according to CA9 levels in patients with HCC. Patients with high serum CA9 concentrations had an increased mortality risk (hazard ratio (HR) 1.690, 95% confidence interval (CI) 1.017–2.809, p = 0.043). B Mortality according to CA9 levels in patients with cirrhosis. Patients with high serum CA9 concentrations had an increased mortality risk in this cohort (hazard ratio (HR) 2.458, 95% confidence interval (CI) 1.010–6.114, p = 0.048).

Article Snippet: CA9 was measured using a commercially available sandwich ELISA (Quantikine Elisa, Human Carbonic Anhydrase IX Immunoassay, DCA900, RND Systems) according to the recommendation of the manufacturer.

Techniques:

Univariate and multivariate analyses of parameters associated with overall survival in HCC patients.

Journal: PLoS ONE

Article Title: Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis

doi: 10.1371/journal.pone.0200855

Figure Lengend Snippet: Univariate and multivariate analyses of parameters associated with overall survival in HCC patients.

Article Snippet: CA9 was measured using a commercially available sandwich ELISA (Quantikine Elisa, Human Carbonic Anhydrase IX Immunoassay, DCA900, RND Systems) according to the recommendation of the manufacturer.

Techniques:

Patient characteristics and tumor stage of CA9 immunohistochemistry in HCC specimen.

Journal: PLoS ONE

Article Title: Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis

doi: 10.1371/journal.pone.0200855

Figure Lengend Snippet: Patient characteristics and tumor stage of CA9 immunohistochemistry in HCC specimen.

Article Snippet: CA9 was measured using a commercially available sandwich ELISA (Quantikine Elisa, Human Carbonic Anhydrase IX Immunoassay, DCA900, RND Systems) according to the recommendation of the manufacturer.

Techniques: Immunohistochemistry

Representative pictures (magnification 10x) of CA9 staining. White bar represents 100μm. A HCC of a patient with cryptic cirrhosis, CA9 score 4. B HCC of a patient with HCV cirrhosis, CA9 score 3. C HCC of a patient with ethanol induced cirrhosis and necrotic area, CA9 score 3. D Non-tumorous area in cryptic cirrhosis with ductular reactions. E Non-tumorous area in NASH cirrhosis with ductular reactions. F Non-tumorous area in ethanol induced cirrhosis with ductular reactions. The evaluation of the immunostainings was done according to the publication of Kang et al., score 0: no expression, score 1: <5% weakly membranous staining, score 2: 5-<25%, score 3: 25-<50%, score 4: 50-<75%, score 5: >75% moderately to strongly membranous staining.

Journal: PLoS ONE

Article Title: Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis

doi: 10.1371/journal.pone.0200855

Figure Lengend Snippet: Representative pictures (magnification 10x) of CA9 staining. White bar represents 100μm. A HCC of a patient with cryptic cirrhosis, CA9 score 4. B HCC of a patient with HCV cirrhosis, CA9 score 3. C HCC of a patient with ethanol induced cirrhosis and necrotic area, CA9 score 3. D Non-tumorous area in cryptic cirrhosis with ductular reactions. E Non-tumorous area in NASH cirrhosis with ductular reactions. F Non-tumorous area in ethanol induced cirrhosis with ductular reactions. The evaluation of the immunostainings was done according to the publication of Kang et al., score 0: no expression, score 1: <5% weakly membranous staining, score 2: 5-<25%, score 3: 25-<50%, score 4: 50-<75%, score 5: >75% moderately to strongly membranous staining.

Article Snippet: CA9 was measured using a commercially available sandwich ELISA (Quantikine Elisa, Human Carbonic Anhydrase IX Immunoassay, DCA900, RND Systems) according to the recommendation of the manufacturer.

Techniques: Staining, Expressing